Laboratory & Research Equipment in New Jersey
8 vendors serving New Jersey
Find laboratory & research equipment vendors in New Jersey. MedIndexer lists vendors headquartered in New Jersey alongside nationwide vendors that serve New Jersey. Compare profiles, review service areas, and contact vendors directly — no middleman, no fees for buyers.
Top laboratory & research equipment in New Jersey
SP Bel-Art & SP Wilmad
SP Bel-Art and SP Wilmad, part of SP Scienceware under SP Industries, are prominent providers of laboratory consumables, plastic labware, scientific glassware, and related equipment. They serve various sectors, including research, industrial, healthcare, pharmaceutical, and life sciences, with a commitment to quality and innovation. Founded in 1946, the company has a rich history of manufacturing, starting with household items before transitioning to laboratory products. Key developments include the formation of Maddak, Inc. in 1971, the acquisition of H-B Instrument in 2012, and the integration into SP Industries in 2014. SP Bel-Art offers a wide range of labware items, while SP Wilmad-LabGlass specializes in precision scientific glassware. Their services include calibration, glass repair, and custom manufacturing. The company is recognized for its contributions to the industry, including receiving the Presidential “E” Award for export excellence.
Sampled
Sampled is a fully integrated analytical laboratory and biorepository based in Piscataway, NJ. The company specializes in extracting valuable data from biological samples to support health innovations. Formerly known as Infinity BiologiX, Sampled has rebranded to emphasize its SMART Lab services, which include storing, managing, analyzing, researching, and transporting biological materials. With nearly 25 years of experience, it operates labs across the US, Europe, and partner facilities in the Netherlands, China, and Australia. Sampled offers a range of services throughout the sample lifecycle, including high-capacity biorepository storage, secure sample management, multiomics processing, and cellular services. The company is known for its pioneering work, such as developing the first FDA-authorized saliva-based COVID-19 test. Sampled collaborates with various health innovators, academic researchers, and industry partners, contributing to significant studies and projects in the field of health and genomics.
Merck
Merck & Co., known as MSD outside the United States and Canada, is a prominent global biopharmaceutical company dedicated to developing innovative prescription medicines, vaccines, biologic therapies, and animal health solutions. Founded in 1891, Merck has a rich history that includes significant contributions to medical science, such as the first effective tuberculosis treatment and the development of the first statin drug. With over 68,000 employees in 120 countries, Merck emphasizes research and development to enhance disease prevention and treatment for both humans and animals. The company offers a diverse portfolio that includes vaccines for diseases like smallpox, measles, and mumps, as well as a range of prescription medicines and biologic therapies. Merck also provides veterinary solutions, reflecting its commitment to animal health. Through its extensive distribution network, Merck serves healthcare markets worldwide, supporting physicians, pharmacists, and veterinary professionals.
GENEWIZ from Azenta Life Sciences
GENEWIZ, a brand under Azenta Life Sciences, is a global leader in multiomics and synthetic solutions services. Founded in 1999, the company specializes in high-quality genomics services, including next-generation sequencing (NGS), Sanger sequencing, and gene synthesis. GENEWIZ supports a wide range of institutions, such as academic, pharmaceutical, biotechnology, government, and healthcare organizations, by providing precision-based solutions that enhance research progress in drug development, clinical research, and advanced cell therapies. The company offers a comprehensive portfolio of services, including various sequencing options, gene synthesis, and specialized compliant services. GENEWIZ also provides clinical and preclinical support, ensuring adherence to regulatory standards. Their emerging solutions include AAV gene therapy services, which focus on transgene expression cassettes and long-read sequencing. With a commitment to superior data quality and fast turnaround times, GENEWIZ positions itself as a trusted partner for leading organizations in diverse fields, including agriculture, cancer research, and synthetic biology.
GenScript
GenScript Biotech Corporation is a global biotechnology company founded in 2002 in New Jersey, USA. It specializes in life science services and products that support innovation in biotech, healthcare, and pharmaceuticals. The company is publicly traded on the Hong Kong Stock Exchange and reported USD 358.5 million in revenue for the fiscal year ending December 31, 2022, reflecting a 12% year-over-year growth. GenScript began as a pioneer in custom gene synthesis and has expanded its offerings to include peptide synthesis, protein production, antibody development, and synthetic biology products. The company operates through its Life Science Group, providing services such as gene and DNA synthesis, CRISPR services, and life-science equipment. GenScript serves over 100,000 researchers globally, including those in academia and major pharmaceutical companies, and is recognized for its fast turnaround, high quality, and reliable support.
CooperGenomics
CooperGenomics, a division of CooperSurgical, specializes in reproductive genetic testing services aimed at enhancing fertility and women's health. With over 27 years of experience, the company is a leader in preimplantation genetic testing (PGT), having performed more than 500,000 procedures. Their expertise includes PGT for aneuploidy, monogenic disorders, and structural rearrangements, making them a pioneer in the field. The company offers a variety of genetic testing and counseling services tailored for IVF embryos. Their services include PGT-A, PGT-M, PGT-SR, and PGT-Complete℠, which combines multiple analyses for informed transfer decisions. They also provide ER-Complete℠ to optimize embryo transfer timing and the largest team of board-certified genetic counselors in the industry. CooperGenomics is dedicated to supporting patients and physicians throughout the fertility journey with advanced genetic testing laboratories.
Allentown, LLC
Allentown, LLC is a global provider of life science solutions, specializing in precision-engineered equipment and advanced vivarium systems for biomedical research. Founded in 1968 by Michael A. Coiro Sr., the company has over 50 years of experience dedicated to the life science industry. Headquartered in Allentown, New Jersey, Allentown operates with a strong commitment to quality and innovation. The company offers a range of high-quality products, including vivarium cages and housing systems for rodents, laboratory housing equipment, connected devices for remote monitoring, and advanced airflow systems. Allentown's products are designed for efficiency and ease of use, available in both single-use and reusable formats. The company also provides exceptional customer support through specialized teams that assist with facility design, installation, training, and ongoing support. Allentown is committed to sustainability, utilizing solar energy at its headquarters and designing products with environmental considerations. With a presence in over 54 countries and a focus on precision engineering and integrity, Allentown positions itself as a trusted partner in the biomedical research community.
Endomedix, Inc.
Endomedix, Inc. is a biotechnology and medical device company based in Montclair, New Jersey, founded in July 2014. The company focuses on developing innovative medical solutions using its patented precision polysaccharide chemistry platform. This technology allows for the creation of dynamic, structured medical devices during surgery, offering unique biomaterials with specialized mechanisms of action. The flagship product, PlexiClot™ Absorbable Hemostat, is designed to control bleeding in brain and spinal surgeries. It addresses a significant challenge in neurosurgery, targeting a $1.9 billion market. PlexiClot has demonstrated its effectiveness in large animal trials and is on track for FDA approval as the first device specifically for brain surgery. The company aims to reduce hospital costs associated with complications, including re-operations and extended hospital stays. Endomedix is led by a team with extensive experience in medical technology and regulatory affairs, supported by a network of physician investors. The company is currently in the prototype-ready stage, preparing for production scale-up and regulatory pathways.